A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
AO GENERIUM
Kineta Inc.
Cambridge University Hospitals NHS Foundation Trust
Imperial College London
University Hospital, Clermont-Ferrand
Weprom
SpeciCare
Sun Yat-sen University
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)